High expression of DRP1 and its adaptors has been associated with poor survival in several adult tumor types, including breast carcinoma (13, 58), nasopharyngeal carcinoma (17), lung carcinoma (11), and hepatocellular carcinoma (14, 15, 59, 60). Here, DNM1L is linked to neoplasm.